Surreal illustration of a diabetic foot ulcer with bacteria and bone structure.

Diabetic Foot Ulcers: How to Beat the Infection Risk

Author's portrait.
Mira Elwood in Health & Wellness December 2025 • 4 min read.

"New Research Reveals the Critical Link Between Osteomyelitis and Drug-Resistant Infections in Diabetic Foot Ulcers."


Diabetic foot ulcers (DFUs) are a frequent and severe complication of diabetes, affecting millions worldwide. More than half of these ulcers become infected, significantly increasing the risk of lower extremity amputation, reducing quality of life, and creating substantial financial burdens. It’s a challenging situation, but understanding the risks and taking proactive steps can make a real difference.

One of the most concerning developments in DFU management is the rise of multidrug-resistant infections. These infections are notoriously difficult to treat and can lead to poorer outcomes, including higher amputation rates and lower healing rates. Preventing these infections is crucial for improving the lives of those living with diabetes and foot ulcers.

Recent research has shed light on a significant connection: the relationship between osteomyelitis (bone infection) and the risk of drug-resistant infections in DFUs. By understanding this link, healthcare providers and individuals can take targeted action to minimize risks and promote better healing.

Osteomyelitis: The Gateway to Drug-Resistant Infections in Diabetic Foot Ulcers

Surreal illustration of a diabetic foot ulcer with bacteria and bone structure.

A comprehensive meta-analysis, pooling data from multiple studies, has revealed a strong association between osteomyelitis and drug-resistant infections in diabetic foot ulcers. The analysis, which included data from 1526 patients across eleven studies, found that patients with osteomyelitis had significantly higher odds of developing drug-resistant infections. Specifically, the summary odds ratio (OR) was 3.343, indicating a more than threefold increased risk.

This connection highlights a critical challenge in managing DFUs. When osteomyelitis is present, the infection can create an environment that fosters the development and spread of drug-resistant bacteria. This is partly due to the prolonged use of broad-spectrum antibiotics often required to treat bone infections, which can inadvertently select for resistant strains.

  • The Meta-Analysis Findings: The meta-analysis showed a statistically significant summary odds ratio (OR) of 3.343 (95% CI = 2.355-4.745; Z = 6.75, P < .00001) when comparing patients with osteomyelitis to those without. This indicates a strong association between osteomyelitis and the risk of drug-resistant infections.
  • Subgroup Analysis: Subgroup analysis based on the type of drug resistance revealed that the summary OR was 4.391 (95% CI = 2.287-8.394) for methicillin-resistant infections and 2.693 (95% CI = 1.882-3.851) for multidrug-resistant infections. This suggests that the risk varies depending on the specific type of resistance.
  • Publication Bias: The initial analysis indicated significant publication bias, but sensitivity analysis using only adjusted odds ratios confirmed the robustness of the findings, with a summary OR of 4.081 (95% CI = 2.471-6.739).
The meta-regression analysis further explored potential factors influencing the risk but found no significant relationship between drug-resistant incidence or publication year and the odds ratio changes. This suggests that the association between osteomyelitis and drug-resistant infections remains consistent across different settings and time periods.

How to Protect Your Feet: Practical Steps for Prevention

The study's conclusion emphasizes that osteomyelitis complications are significantly related to the risk of drug-resistant infections in diabetic foot ulcers. The researchers advocate for bone culture-based, narrow-spectrum antibiotic therapy for osteomyelitis to prevent drug-resistant infections in diabetic foot ulcers.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What are diabetic foot ulcers, and why are they a serious concern for individuals with diabetes?

Diabetic foot ulcers (DFUs) are open sores that develop on the feet of people with diabetes. They are a significant concern because more than half of these ulcers become infected, elevating the risk of lower extremity amputation, diminishing quality of life, and imposing substantial financial burdens. The prevalence of these ulcers and their complications underscores the importance of understanding and managing these conditions effectively.

2

How does osteomyelitis increase the risk of drug-resistant infections in diabetic foot ulcers?

Osteomyelitis, or bone infection, is strongly associated with drug-resistant infections in DFUs. The prolonged use of broad-spectrum antibiotics, often necessary to treat osteomyelitis, can inadvertently foster the development and spread of drug-resistant bacteria. The meta-analysis found that patients with osteomyelitis had a significantly higher chance of developing drug-resistant infections, with a summary odds ratio of 3.343, indicating more than a threefold increase in risk.

3

What were the key findings from the meta-analysis regarding osteomyelitis and drug-resistant infections in DFUs?

The meta-analysis revealed a strong association between osteomyelitis and drug-resistant infections in diabetic foot ulcers. The summary odds ratio (OR) was 3.343, with a statistically significant result, indicating a substantially increased risk. Subgroup analysis showed that the risk varies depending on the type of drug resistance; for example, the summary OR was 4.391 for methicillin-resistant infections. The analysis also addressed publication bias and confirmed the robustness of the findings even after adjustments.

4

What specific types of drug resistance were examined in relation to osteomyelitis in the meta-analysis?

The meta-analysis specifically examined the association between osteomyelitis and the risk of different types of drug resistance. Subgroup analysis explored methicillin-resistant infections and multidrug-resistant infections. The summary OR for methicillin-resistant infections was 4.391, and for multidrug-resistant infections, it was 2.693. These results demonstrate how the risk of drug resistance varies depending on the specific type.

5

What practical steps can be taken to prevent drug-resistant infections in diabetic foot ulcers, based on the study's conclusions?

According to the study's conclusions, one of the key strategies to prevent drug-resistant infections in DFUs is to use bone culture-based, narrow-spectrum antibiotic therapy for osteomyelitis. This approach helps to target the specific bacteria causing the infection and minimizes the use of broad-spectrum antibiotics, which can contribute to the development of resistance. This targeted approach is crucial for better outcomes and minimizing the risk of serious complications.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.